Tested Applications
| Positive WB detected in | mouse liver tissue |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20028-1-AP targets MED12 in WB, IHC, IF/ICC, ChIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | mediator complex subunit 12 |
| Calculated Molecular Weight | 243 kDa |
| Observed Molecular Weight | 243 kDa |
| GenBank Accession Number | NM_005120 |
| Gene Symbol | MED12 |
| Gene ID (NCBI) | 9968 |
| RRID | AB_10644141 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q93074 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Mediator of RNA polymerase II transcription subunit 12 (MED12), also named Activator-recruited cofactor 240 kDa component, Thyroid hormone receptor-associated protein complex 230 kDa component. MED12 is a component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. This subunit may specifically regulate transcription of targets of the Wnt signaling pathway and SHH signaling pathway. Molecular weight of MED12 is about 240kd.This antibody is specific to MED12.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for MED12 antibody 20028-1-AP | Download protocol |
| WB protocol for MED12 antibody 20028-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
20028-1-AP MED12 Polyclonal antibody has 8 citations.
Journals include Nature Chemical Biology, EMBO Journal, Modern Pathology, Functional & Integrative Genomics, Naunyn-Schmiedeberg's Archives of Pharmacology, Pathology - Research and Practice, Genes (Basel), and bioRxiv.
Research fields span cancer oncology (uterine leiomyoma/leiomyosarcoma, rhabdomyosarcoma, non-small cell lung cancer), gene transcription regulation (MED12/mediator complex, RNA Pol II, STAT1 axis), stem cell pluripotency and mitochondrial biology, cardiovascular disease (aortic dissection, hepatic ischemia-reperfusion injury), and CD8+ T cell immunotherapy.
Applications cited include WB, IHC, IF, and ChIP.
| Species | Application | Title |
|---|---|---|
Nat Chem Biol MED1 IDR deacetylation controls stress responsive genes through RNA Pol II recruitment | ||
EMBO J Fatty acid synthesis is critical for stem cell pluripotency via promoting mitochondrial fission. | ||
Mod Pathol MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. | ||
Naunyn Schmiedebergs Arch Pharmacol Loureirin B improves H/R-induced hepatic ischemia-reperfusion injury by downregulating ALOX5 to regulate mitochondrial homeostasis | ||
Funct Integr Genomics MED12-STAT1-TAP2 axis regulates CD8 + T cell cytotoxicity and mediates immunotherapy outcome in non-small cell lung cancer | ||
Pathol Res Pract Cyclin-dependent kinase 8 is an independent prognosticator in uterine leiomyosarcoma. |





